Bulexin 4 mg / 1 mg sublingual tablets

Licence status
Authorised: 20/12/2024
Active substances
Buprenorphine hydrochloride , Naloxone hydrochloride dihydrate
Dosage Form
Sublingual tablet
Licence number
PA0281/267/002
Licence holder
Pinewood Laboratories Ltd

Product documents

Licence information

ATC code
N07BC51 buprenorphine, combinations
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Conditions of Licence
Medicinal product subject to restricted medical prescription (See Summary of Product Characteristics, section 4.2). This product contains a substance listed in Schedule 2 to the Misuse of Drugs Regulations 2017.
Marketing availability
Not marketed
Advertising conditions
Advertising to healthcare professionals only
Licence issued
20/12/2024